Self-Collection for Cervical Cancer Screening and HPV Vaccination for Cancer Prevention Among Women in Emergency Care in Northeast Florida

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-65
SponsorMayo Clinic

About this trial

Human Papilloma Virus (HPV) is a cause of cervical cancer in women. This study is being done to identify sites for cervical cancer screening and education regarding HPV vaccination outside of the traditional settings of primary care and gynecologic clinics. Identifying non-traditional cancer screening settings may increase cancer screening completion and HPV vaccination among women with limited health care knowledge and access who are vulnerable to health disparities.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Adults assigned as female at birth age 18-65 with a Mayo Clinic medical record number

Disqualifiers

Adults assigned as female at birth age 0-17

Adults assigned as female at birth age > 65

Adults assigned as male at birth

Adults assigned as female at birth without a Mayo Clinic medical record number

Trial population

Female patients recruited after previous ED visits

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Non-Interventional Study

    Other intervention

    Non-Interventional study

Treatment groups

100 Participants
are divided into 2 treatment groups
Group A: Observational aim 1 & aim 31 intervention
Group B: Observational aim 21 intervention

Trial outcomes

Primary outcomes

1

Human Papilloma Virus (HPV) sample self-collection following Emergency Department (ED) presentation

Will be assessed by the percentage of women between 25-65 eligible for cervical cancer screening who participate or who opt not to participate in self-collection.

Time frame
Baseline
2

HPV vaccination following ED presentation

Will be assessed by the percentage of women between 18-26 eligible for HPV vaccination for cervical cancer prevention who participate in HPV vaccination. Participants will be contacted one month after initial contact to determine if the HPV vaccination was administered.

Time frame
One month
3

Interviews of women who decline self-collection

Phone or video-based interviews will be conducted with eligible participants who decline self-collection to determine reasons for non-participation.

Time frame
Baseline
4

Interviews of women who consent to self-collection but do not complete the self-collection

Phone or video-based interviews will be conducted with participants who agree to participate but do not complete self-collection after 4 weeks to determine reasons for non-participation.

Time frame
Up to 6 weeks

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: